Neurothrombectomy Devices Market Forecasts to 2030 – Global Analysis By Product (Clot Retrievers, Aspiration/Suction Devices and Vascular Snares), Type (Retriever, Integrated System and Other Types), Application and By Geography

Neurothrombectomy Devices Market Forecasts to 2030 – Global Analysis By Product (Clot Retrievers, Aspiration/Suction Devices and Vascular Snares), Type (Retriever, Integrated System and Other Types), Application and By Geography

According to Stratistics MRC, the Global Neurothrombectomy Devices Market is accounted for $816 million in 2023 and is expected to reach $1463.3 million by 2030 growing at a CAGR of 8.7% during the forecast period. A neurothrombectomy is performed to remove or dissolve blood clots in the cerebral neurovasculature utilizing laser, mechanical, and ultrasound technologies. It is primarily used to speed up recanalization, treat large vascular occlusions more successfully, and lower the risk of hemorrhagic episodes. Additionally, it helps to increase functional results and lower patient death rates.

According to the CDC, in the U.S., there are more than 795,000 stroke victims annually. Of these, about 610,000 are new or first strokes.

Market Dynamics:

Driver:

Increasing Prevalence of Acute Ischemic Strokes

As the incidence of strokes rises due to factors like aging populations and lifestyle changes, the demand for effective stroke interventions grows. Neurothrombectomy devices, designed to swiftly remove blood clots causing these strokes, become crucial tools in enhancing patient outcomes. The urgency to provide timely and efficient treatment aligns with the need for advanced devices, propelling research, development, and adoption. This driver underscores the market's role in addressing a critical medical need and improving stroke management practices across diverse patient populations.

Restraint:

High cost of neurothrombectomy devices

While these devices offer advanced stroke treatment solutions, their affordability can hinder widespread adoption. Healthcare systems, patients, and insurers might face challenges in covering the expenses of these specialized devices, impacting accessibility. Manufacturers must balance the need for advanced technology with cost-effectiveness to ensure broader market penetration. Collaborations with healthcare institutions and research organizations, along with technological advancements, are crucial in addressing this restraint, making innovative stroke treatment options more accessible and aligning with the goal of improving patient outcomes.

Opportunity:

Increase in geriatric population

As the elderly demographic expands, the prevalence of acute ischemic strokes, often associated with age-related health issues, also rises. This demographic shift drives heightened demand for advanced and effective stroke intervention solutions. Neurothrombectomy devices are designed to rapidly remove the blood clots causing these strokes. Manufacturers have the opportunity to develop and refine specialized devices tailored to the needs and anatomical variations of older patients. Additionally, this trend highlights the necessity of expanding stroke treatment access, education, and awareness among healthcare providers, caregivers, and the aging population themselves.

Threat:

Risks associated with neurothrombectomy procedure

While these devices offer vital stroke treatment solutions, the procedure itself carries potential complications such as vessel perforation, bleeding, or embolization. The complexity of the procedure requires skilled medical professionals and proper patient selection. Public and professional awareness of the potential risks could affect patient willingness to undergo the procedure. Device manufacturers must prioritize safety features, provide comprehensive training, and collaborate with healthcare providers to mitigate these risks, ensuring that the benefits of neurothrombectomy devices outweigh the potential hazards, thereby maintaining patient trust and market sustainability.

Covid-19 Impact:

The COVID-19 pandemic impacted the market by directly affecting demand and production, upsetting the supply chain, and driving up costs for businesses. The effect of the pandemic on the market varies by nation depending on the quality of the local health systems and the measures taken to combat it. Neurocare and neurosurgeons suffered as a result of the pandemic. To avoid the coronavirus from spreading, brain surgeries have frequently been postponed or even canceled during this period. The worst-affected nations, which included the United States, Russia, India, Brazil, France, the United Kingdom, Italy, and Spain, saw a 55% decline in neurosurgical procedures.

The ambulatory surgical centers segment is expected to be the largest during the forecast period

The ambulatory surgical centers neurothrombectomy devices segment is expected to have a lucrative growth. This variant is created by blending aged rums with a selection of spices, allowing for a harmonious marriage of oak-infused notes and exotic spices. The aging process imparts depth and richness to the rum, while the infusion of spices adds a layer of warmth and complexity. Discerning rum enthusiasts and connoisseurs appreciate the craftsmanship behind aged Neurothrombectomy Devices, making it a sought-after choice for sipping or crafting premium cocktails. As the demand for premium and artisanal spirits continues to rise, aged Neurothrombectomy Devices remains a significant contributor to the overall growth of the spice rum market.

The aspiration/suction devices segment is expected to have the highest CAGR during the forecast period

The aspiration/suction devices segment is anticipated to witness the fastest CAGR growth during the forecast period. These specialized tools are designed to effectively remove blood clots from cerebral blood vessels during ischemic strokes. By creating a vacuum force, these devices gently and precisely extract the clot, restoring blood flow and minimizing potential damage. The use of aspiration devices, often in conjunction with catheters, offers a minimally invasive approach to thrombectomy procedures, reducing the risk of complications. As technology advances, these devices are becoming more refined, efficient, and adaptable to varying clot sizes and locations, contributing significantly to improved patient outcomes and the evolution of stroke treatment practices.

Region with largest share:

During the forecast period, it is expected that the Europe Neurothrombectomy Devices market will continue to hold a majority of the market share with a rising demand for advanced stroke treatment solutions. With a growing aging population and increasing cases of ischemic strokes, there is a pressing need for effective neurothrombectomy devices. European healthcare systems' emphasis on quality care and access to innovative treatments propels market growth. Regulatory approvals, research collaborations, and technological breakthroughs drive device development. Additionally, the adoption of minimally invasive techniques and the integration of artificial intelligence further shape the market's trajectory, offering hope for improved patient outcomes and reduced stroke-related disabilities across the European region.

Region with highest CAGR:

The Asia Pacific region plays a significant role in the spice rum market and is projected to have the highest CAGR over the forecast period, driven by a rapid urbanization, lifestyle changes, and an aging population contribute to a rising incidence of ischemic strokes. The region's healthcare sector is increasingly adopting innovative technologies to address these challenges. Government initiatives, growing healthcare infrastructure, and rising awareness of stroke management fuel market expansion. Collaboration between healthcare institutions and device manufacturers fosters research and development, driving device innovation. As Asia Pacific countries focus on enhancing healthcare access and outcomes, the Neurothrombectomy Devices market offers opportunities to provide effective stroke treatments and improve patients' quality of life.

Key players in the market

Some of the key players in Neurothrombectomy Devices market include Medtronic, Terumo Corporation, Penumbra Inc., Stryker Corporation, Acandis GmbH, Argon Medical, Edward Lifesciences Corporation, Inari Medical, Johnson & Johnson, Abbott Laboratories, Vesalio and Phenox GmbH.

Key Developments:

In December 2022, Medtronic launched its Solitaire(TM) X Revascularization Device in the U.S., used to remove blood clots mechanically from blood vessels and restore revascularization rate in patients suffering from acute ischemic stroke.

In August 2022, Penumbra, Inc. received the U.S. FDA clearance for its RED 62 Reperfusion Catheter to navigate and deliver aspiration to remove blood clots in acute ischemic patients with large vessel occlusions.

In March 2022, the Society of Vascular and Interventional Neurology (SVIN) and NeuroPoint Alliance (NPA) will work together to create the NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD). The NVQI-QOD neurovascular registry is focused on enhancing clinical care and outcomes for patients with stroke and intracranial cerebrovascular illnesses, and the project, according to the statement, broadens and deepens its scope.

Products Covered:
• Clot Retrievers
• Aspiration/Suction Devices
• Vascular Snares

Types Covered:
• Retriever
• Integrated System
• Other Types

Applications Covered:
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers
• Public Health Labs
• Private or Commercial Labs
• Physician Labs
• Research Institutes
• Other Applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements




Companies Mentioned
Medtronic
Terumo Corporation
Penumbra Inc.
Stryker Corporation
Acandis GmbH
Argon Medical
Edward Lifesciences Corporation
Inari Medical
Johnson & Johnson
Abbott Laboratories
Vesalio
Phenox GmbH